'Scout scans' map the way in non-Hodgkin's lymphoma treatment

According to a study presented at SNM's 57th Annual Meeting, molecular imaging can evaluate and optimise non-Hodgkin's lymphoma therapy with Zevalin, a front-line radioimmunotherapy drug that uses a dose of radioactive material and mimics the body's own immune response to target and kill cancer cells while sparing nearby healthy tissues...

Read the whole article on

More from